Radium-223 Therapy — For Prostate Cancer Bone Metastases

The reason it lands where it needs to is chemistry, not aim. Radium behaves in the body much like calcium. Bone that is being broken down and rebuilt around a cancer deposit pulls in calcium fast, so it pulls in radium-223 fast too. No machine is pointed at anything. Your own bone turnover does the targeting.

That places this treatment in a family called theranostics — treatment with radioactive medicine, where the isotope is carried to the disease from the inside rather than beamed at it from outside. It is a different idea from the daily radiation sessions most families picture, and it is scheduled very differently too.

This page answers the three questions that come up first in a palliative-stage consultation: what it treats, how many injections are involved, and what it is realistically meant to achieve. It is written for men already deep into treatment and for the families coordinating around them.

Radium-223 is delivered at an NABH-accredited partner nuclear medicine centre holding the required regulatory licence; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate a nuclear medicine facility, a linear accelerator or any other radiotherapy equipment.

The organ question is the one families are least prepared for. A bone-seeking isotope goes to bone. If imaging shows deposits in the liver or the lungs, those deposits are simply not reached, so a treating team will usually direct you to a systemic option instead. This is a decision made from your current scans, not from how well or how badly you feel on the day.

When it is usually considered

• Prostate cancer with spread to bone, confirmed on a bone scan or a PET-CT.
• Bone pain or other bone-related symptoms that are affecting daily life.
• Disease that has continued to progress on hormone-directed treatment.
• No cancer deposits in organs such as the liver or lungs on current imaging.
• Haemoglobin, white cells and platelets high enough to start and to keep going.
• Fit enough to attend one short outpatient appointment every four weeks.

When something else usually comes first

• Spread to the liver, lungs or other organs, or bulky lymph node disease — a bone-seeking isotope does not reach any of it.
• Blood counts below the treating centre's threshold, at least until they recover.
• Pressure on the spinal cord, or a bone at risk of breaking — these are urgent and are handled first, usually with external beam radiation or an orthopaedic procedure.
• Widespread bone pain from a cancer other than prostate cancer — that is managed on a different route, covered on our page about samarium and strontium injections for widespread bone pain.

Guideline bodies including NCCN and ESMO place bone-targeted radioisotope treatment in the advanced, previously treated setting for bone-only or bone-dominant disease. It is not an alternative to surgery or to standard radiation for localised prostate cancer.

Six is the plan, not a promise. Every appointment is a fresh decision made on that day's blood test and that month's symptoms. Here is what one round actually looks like.

Coordinating for a father or a husband from another city or from abroad? Plan around the rhythm rather than one long trip: one short hospital day roughly every four weeks, with ordinary hygiene precautions at home for about a week after each.

This is the question where honest wording matters most, because “achieve” means two different things in the same consultation room. One is a symptom goal — less bone pain, fewer bone problems, more of the day spent doing something other than managing pain. The other is a disease-control goal, judged on scans and blood tests over months.

We do not publish survival figures on this page. Numbers lifted out of a trial and dropped onto a stranger's situation are misleading, and guideline bodies including NCCN, ESMO and ASTRO frame this treatment by setting and by intent rather than by a headline figure. Whatever number you are quoted, ask which report of yours it was applied to. If the answer is “none”, it is not a number about you.

What it is not designed to do

• It does not treat deposits in the liver, lungs, lymph nodes or anywhere outside bone.
• It does not replace hormone-directed treatment decisions, which continue to be made by your oncologist.
• It does not fix a bone that has already broken, or relieve pressure on the spinal cord. Both are urgent and need external beam radiation or surgery, not an injection given four weeks apart.
• It is not a painkiller. Pain relief, if it comes, builds over weeks. Your prescribed pain control continues alongside it.

How it sits beside the other bone-directed options

These are not competing products. In practice a man may have external beam radiation to one painful hip, a course of a bone-seeking isotope for the wider picture, and bone-protecting injections running through both. The sequence is a treating-team decision.

This is the practical difference between Radium-223 and the isotopes people have read about online. Most protocols need no shielded room and no separation from family. You sit in your own home, sleep in your own bed, and follow a short hygiene sheet: flush after use, wash hands properly, clean up spills promptly, wash soiled clothing separately. If you are sexually active, your team will advise contraception for a defined period and will put the dates in writing.

Family members and attendants are not at risk when those written rules are followed. Ask for the sheet to be explained to whoever will actually be at home, not only to the patient.

What side effects are common

The ones most often reported are nausea, loose stools or diarrhoea, vomiting, tiredness, and a fall in blood counts — which is why a blood test comes before every injection. A short flare of bone pain in the first days after an injection also happens and usually settles. Our guide to the side effects of radioisotope therapy goes through the pattern across this whole family of treatments and what typically helps.

Call your team the same day for fever, unusual bruising or bleeding, sudden severe pain, or new weakness, numbness or difficulty passing urine. That last group can signal pressure on the spinal cord and is treated as an emergency — call 1800 202 8726 or go to the nearest emergency department.

The sequence in practice is: a consultation with your records reviewed, imaging to confirm the disease is bone-confined or bone-dominant, blood tests, a treating-team decision, then a scheduled first injection. Dates depend on isotope stock and on the partner centre's slots, so they are confirmed rather than assumed. Ask for them in writing.

If you are arranging this from outside Hyderabad

Reports can be reviewed before anyone books a ticket, which means the eligibility conversation happens before the journey rather than after it. Once a course starts, the commitment is one short hospital day roughly every four weeks for up to five months, and the appointments have to stay reasonably on schedule.

What about cost?

Bone-directed radioisotope treatment is quoted per injection rather than as a single package, and the scans and blood tests around it are billed separately. Because the number of injections you actually receive is reviewed as you go, the total is a range and not a fixed figure. Any estimate you are given is indicative, as of August 2026, and moves with the centre, the protocol and stock availability. Our page on the cost of theranostics and radioisotope therapy in India sets out what an itemised estimate should contain, and what insurance and government schemes typically do and do not cover.

Ask for a written, itemised estimate naming exactly what is included — scans, blood tests, the injection, monitoring, follow-up — before you commit to a course.

• Widespread bone pain, or a cancer other than prostate? Read Samarium and Strontium Injections for Widespread Bone Pain, which covers the beta-emitting isotopes used when the aim is symptom relief across several cancer types.
• Worried about how you will feel through a course? Side Effects of Lu-177 and Radioisotope Therapy sets out the pattern common to this whole family of treatments and what usually helps.
• Tumours in the liver rather than the bones? Y-90 Radioembolisation for Liver Tumours explains the equivalent idea for liver disease, where the isotope is delivered through the blood supply to the tumour.
• A neuroendocrine diagnosis in the family instead? Lu-177 DOTATATE for Neuroendocrine Tumours covers the receptor-targeted version of the same principle.
• Want the wider picture first? Radiation Therapy at CION Cancer Clinics sets out how external beam radiation, brachytherapy and radioisotope treatments are each planned and coordinated with NABH-accredited partner centres.

Have a bone scan or PET-CT report already? Book a free consultation or call 1800 202 8726 and have it reviewed this week.